Evidence map›Paper›PMID 30930169›Full record

ArticleCell metabolism2019

Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease.

Hisayuki Amano, Arindam Chaudhury, Cristian Rodriguez-Aguayo, Lan Lu, Viktor Akhanov, Andre Catic, Yury V Popov, Eric Verdin, Hannah Johnson, Fabio Stossi and 9 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04962464 (The Impact of Fasting Mimicking Diet Program and Calorie Mimetic Supplements on Epigenetic Aging), which is not on this map. Cited by 109 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 3 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04962464 phase2unknown statusnot on this mapstarted 2021, after this paper: background citation

The Impact of Fasting Mimicking Diet Program and Calorie Mimetic Supplements on Epigenetic Aging

TypeinterventionalSponsorTruDiagnosticRan2021 to 2022Enrolled100ConditionsAgingArmsPeak Human Labs calorie mimetic supplement, Fasting Mimicking Diet
3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 3 syntheses or guidelines pooled it, 177 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. NADBiochemistry and biophysics reports · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Period3 modulates the NADJournal of advanced research · 2025
    Article
  17. Article
  18. Article
  19. NADCommunications biology · 2025
    Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 1 country.

Hisayuki AmanoDepartment of Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.
Arindam ChaudhuryDepartment of Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.
Cristian Rodriguez-AguayoDepartment of Experimental Therapeutics & Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Lan LuOncology Informatics & Genomics, Phillips Healthcare, Cambridge, MA 02141, USA.
Viktor AkhanovHuffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.
Andre CaticHuffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.
Yury V PopovDivision of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Eric VerdinGladstone Institute of Virology and Immunology, San Francisco, CA, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Buck Institute for Research on Aging, Novato, CA, USA.
Hannah JohnsonDepartment of Molecular and Cellular Biology & Integrated Microscopy Core, Baylor College of Medicine, Boston, MA, USA.
Fabio StossiDepartment of Molecular and Cellular Biology & Integrated Microscopy Core, Baylor College of Medicine, Boston, MA, USA.
David A SinclairDepartment of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
Eiko Nakamaru-OgisoDepartment of Biochemistry and Biophysics, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Gabriel Lopez-BeresteinDepartment of Experimental Therapeutics & Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jeffrey T ChangDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Joel R NeilsonDepartment of Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.
Alan MeekerDepartment of Pathology, Department of Oncology, Johns Hopkins Medical Institution, Baltimore, MD 21231, USA.
Milton FinegoldDepartment of Pathology, Baylor College of Medicine, Houston, TX 77030, USA.
Joseph A BaurDepartment of Physiology, Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Philadelphia, PA 19104, USA.
Ergun SahinDepartment of Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: esahin@bcm.edu.
Baylor College of Medicine · USHarvard University · USThe University of Texas MD Anderson Cancer Center · USUniversity of Pennsylvania · USBuck Institute for Research on Aging · USJohns Hopkins University · USThe University of Texas Health Science Center at Houston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and AgingR01DK098656 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Joseph A. Baur · 2013 to 2026
$6.1M
Uncovering the Human SecretomeDP1AG058605 · NIA · HARVARD MEDICAL SCHOOL · PI SINCLAIR, DAVID A. · 2017 to 2021
$5.9M
Role of Sgs1 DNA helicase in telomere maintenanceR01AG019719 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SINCLAIR, DAVID A. · 2001 to 2022
$5.3M
SIRT1 as a regulator of health and lifespan of mammalsR37AG028730 · NIA · HARVARD MEDICAL SCHOOL · PI SINCLAIR, DAVID A. · 2012 to 2021
$4.1M
Elucidating mechanisms of SIRT1 activationR01DK100263 · NIDDK · HARVARD MEDICAL SCHOOL · PI SINCLAIR, DAVID A. · 2016 to 2020
$2.5M
Molecular Mechanisms of Rapamycin's Effects on Health and LongevityR01AG043483 · NIA · UNIVERSITY OF PENNSYLVANIA · PI BAUR, JOSEPH A. · 2013 to 2017
$2.0M
Translational control of EMT by the CELF1 RNA Binding ProteinR01CA190467 · NCI · BAYLOR COLLEGE OF MEDICINE · PI NEILSON, JOEL R · 2015 to 2021
$1.9M
Transcript decay regulates hematopoietic agingR01DK115454 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI CATIC, ANDRE · 2017 to 2021
$1.8M
Supplement to existing R01 to increase diversity in health-related scienceR01AG047924 · NIA · BAYLOR COLLEGE OF MEDICINE · PI SAHIN, ERGUN · 2015 to 2019
$1.7M
NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA125123NCI NIH HHS R01 CA190467NIA NIH HHS DP1 AG058605NIA NIH HHS R01 AG019719NIA NIH HHS R01 AG043483NIA NIH HHS R01 AG047924NIA NIH HHS R37 AG028730NIDCR NIH HHS R21 DE027490NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK098656NIDDK NIH HHS R01 DK100263NIDDK NIH HHS R01 DK115454
6 · The paper itself

Abstract

Telomere shortening is associated with stem cell decline, fibrotic disorders, and premature aging through mechanisms that are incompletely understood. Here, we show that telomere shortening in livers of telomerase knockout mice leads to a p53-dependent repression of all seven sirtuins. P53 regulates non-mitochondrial sirtuins (Sirt1, 2, 6, and 7) post-transcriptionally through microRNAs (miR-34a, 26a, and 145), while the mitochondrial sirtuins (Sirt3, 4, and 5) are regulated in a peroxisome proliferator-activated receptor gamma co-activator 1 alpha-/beta-dependent manner at the transcriptional level. Administration of the NAD(+) precursor nicotinamide mononucleotide maintains telomere length, dampens the DNA damage response and p53, improves mitochondrial function, and, functionally, rescues liver fibrosis in a partially Sirt1-dependent manner. These studies establish sirtuins as downstream targets of dysfunctional telomeres and suggest that increasing Sirt1 activity alone or in combination with other sirtuins stabilizes telomeres and mitigates telomere-dependent disorders.

Indexed as

AnimalsCells, CulturedDown-RegulationEmbryo, MammalianFemaleGene Expression Regulation, EnzymologicHEK293 CellsHumansLiverLiver CirrhosisMaleMiceMice, Inbred C57BLMice, KnockoutMitochondria, LiverNicotinamide MononucleotideNicotinamide MononucleotideSirtuin 1SirtuinsTelomeraseTert protein, mouseliver diseasemetabolismp53sirtuinstelomeres

Identifiers

PMID30930169
PMCPMC6657508
OpenAlexW2927492624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.